Beijing, Beijing, China The leading representative office of defined VC is situated in the Beijing. The venture was found in Asia in China.
Deals in the range of 10 - 50 millions dollars are the general things for fund. Considering the real fund results, this VC is 3 percentage points less often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. The important activity for fund was in 2018.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular portfolio startups of the fund, we may highlight GenomePrecision, Campo Imaging. Among the most popular fund investment industries, there are Health Care, Medical. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. The fund has exact preference in a number of founders of portfolio startups.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Yueyin Venture Capital, startups are often financed by ZhenFund, Proxima Ventures Ltd, Anlongmed Fund. The meaningful sponsors for the fund in investment in the same round are Proxima Ventures Ltd, ZhenFund, Yingke Capital. In the next rounds fund is usually obtained by Yizhuang Biomedical Mergers and Acquisition Funds, Sigma Square Capital, Proxima Ventures Ltd.
Related Funds
Funds with similar focus
| Fund Name | Location |
| 40 North Ventures | California, Campbell, United States |
| Bohemian Companies | Colorado, Fort Collins, United States |
| Caledonia Investments | England, London, United Kingdom |
| CenturyLink | Louisiana, Monroe, United States |
| Fasanara Capital | England, London, United Kingdom |
| FIWARE | Berlin, Berlin, Germany |
| Haidian Pioneer Park | Beijing, Beijing, China |
| Hangzhou Joyni Capital Management | China, Hangzhou, Zhejiang |
| Innovatia Inc | Canada, New Brunswick, Saint John |
| Lanchuangda Information Technology | China, Qingdao, Shandong |
| Medinnova | England, Leicester, United Kingdom |
| Mitsubishi Chemical Corporation | Japan, Tokyo |
| MVP Capital | Pennsylvania, Radnor, United States |
| Ningbo Shenya Touzi Guanli Youxian Gongsi | China, Ningbo, Zhejiang |
| Sesame Ventures | New York, New York, United States |
| Shanxi Shenggao Jishu Fuwu Chuangtou | China, Shaanxi, Xian Shi |
| Udaipur Angel Network | - |
| Wiel Brien Investments, LLC, | - |
| Wurk | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Tsingke Biotechnology | $30M | 01 Jan 2022 | Beijing, Beijing, China | ||
GX Pharma | $15M | 24 Sep 2020 | Beijing, Beijing, China | ||
TCR Cure | $1M | 02 Apr 2019 | Nansha District, Guangdong Province, China | ||
Hanyu Medical | $14M | 27 Dec 2018 | Shanghai, China | ||
Yidianling | $2M | 07 Aug 2018 | Shanghai, China | ||
Yidianling | 11 Apr 2018 | Shanghai, China | |||
rivamed | $1M | 04 Jan 2018 | China, Beijing | ||
Campo Imaging | $15M | 24 Nov 2017 | China, Beijing | ||
GenomePrecision | 06 Mar 2017 | China, Beijing |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Tsingke Biotechnology | $30M | 01 Jan 2022 | Beijing, Beijing, China | ||
GX Pharma | $15M | 24 Sep 2020 | Beijing, Beijing, China | ||
TCR Cure | $1M | 02 Apr 2019 | Nansha District, Guangdong Province, China | ||
Hanyu Medical | $14M | 27 Dec 2018 | Shanghai, China | ||
Yidianling | $2M | 07 Aug 2018 | Shanghai, China | ||
Yidianling | 11 Apr 2018 | Shanghai, China | |||
rivamed | $1M | 04 Jan 2018 | China, Beijing | ||
Campo Imaging | $15M | 24 Nov 2017 | China, Beijing | ||
GenomePrecision | 06 Mar 2017 | China, Beijing |
